Status: current, Defined. Date: 30-Sep 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4458091000168112 | Sarclisa (isatuximab 100 mg / 5 mL) injection, 1 x 5 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4458101000168119 | Sarclisa 100 mg/5 mL injection, 5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sarclisa 100 mg/5 mL injection, 5 mL vial | Is a | isatuximab 100 mg/5 mL injection, 5 mL vial | true | Inferred relationship | Some | ||
| Sarclisa 100 mg/5 mL injection, 5 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Sarclisa 100 mg/5 mL injection, 5 mL vial | has TP | Sarclisa | true | Inferred relationship | Some | ||
| Sarclisa 100 mg/5 mL injection, 5 mL vial | has TPUU | Sarclisa 100 mg/5 mL injection, 5 mL vial | true | Inferred relationship | Some | 1474154966 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sarclisa 100 mg/5 mL injection, 5 mL vial | Is a | True | Sarclisa 100 mg/5 mL injection, 5 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR